PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Logging debris gives newly planted Douglas-fir forests a leg-up

Retaining moderate levels of 'slash' linked to increased early growth in seedlings

2013-03-12
(Press-News.org) The downed limbs and other woody debris that are inevitable byproducts of timber harvest could be among the most important components of post-harvest landscapes, according to a new study led by the U.S. Forest Service's Pacific Northwest Research Station.

Researchers found that retaining moderate levels of logging debris, also known as "slash," helped to both directly and indirectly increase the growth rate of Douglas-fir seedlings replanted after harvest. The findings, which are among the first to speak to the benefits of second-growth logging debris, are published online in the journal Forest Ecology and Management.

"At levels typically left after forest harvesting, where 40 percent of the ground is covered by logging debris, we found that debris inhibited the growth of competing herbaceous vegetation and so preserved soil water," said Tim Harrington, a research forester with the station and the study's lead. "This means that just leaving typical levels of debris in place after forest harvesting helps new Douglas-fir seedlings to become established."

The findings are based on a study of seedling development under three levels of logging debris—0, 40, and 80 percent cover—at two sites in Washington and Oregon affiliated with the North American Long-Term Soil Productivity study, a collaborative program launched by Forest Service Research and Development more than two decades ago. Harrington and his colleagues expanded on previous research on logging debris effects by increasing the number of seedlings studied, extending the study period to four years, and looking at the responses of additional variables, like vegetation abundance and seedling water potential.

In addition to having a "vegetation control" effect, the retained woody debris helped promote Douglas-fir seedling growth by reducing evaporation; slowing decomposition and allowing soil carbon and other nutrients to accumulate; and inhibiting the invasion of aggressive, non-native species, including Scotch broom and hairy cat's ear.

These responses occurred where no herbicide treatments were applied. However, where the use of herbicides to control competing vegetation was combined with logging debris, seedling growth rates were the highest observed in the study, especially where debris cover was 80 percent.

"Industrial forest managers and private landowners in Washington and Oregon are already using early results of the study to prevent Scotch broom invasions," Harrington said. "But these new findings suggest that long-term forest productivity will benefit from debris retention, indicating much broader applicability of the research," Harrington said.

### The study was conducted in collaboration with Robert Slesak, University of Minnesota; and Stephen Schoenholtz, Virginia Tech. It will appear in print in a forthcoming issue of the journal.

The Pacific Northwest Research Station—headquartered in Portland, Ore.—generates and communicates scientific knowledge that helps people make informed choices about natural resources and the environment. The station has 11 laboratories and centers located in Alaska, Oregon, and Washington and about 390 employees. Learn more online at http://www.fs.fed.us/pnw.


ELSE PRESS RELEASES FROM THIS DATE:

Drug may improve outcomes after heart attack

2013-03-12
SAN FRANCISCO (March 10, 2013) — The prescription drug eplerenone appears to reduce the risk of cardiovascular mortality and heart failure after a heart attack by more than one-third, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. The REMINDER (Reduction of heart failure morbidity in patients with acute ST-elevation myocardial infarction) trial was a randomized, double-blind trial of 1,012 patients who had a heart attack caused by a complete blockage of one of the heart's arteries. Patients had no signs or ...

Investigational drug reduces heart damage during angioplasty

2013-03-12
SAN FRANCISCO (March 10, 2013) — A single dose of an investigational anti-inflammatory drug, inclacumab, reduced damage to heart tissue during angioplasty in a study presented today at the American College of Cardiology's 62nd Annual Scientific Session. More than 1 million coronary angioplasty procedures are performed in the United States each year, at a cost of more than $10 billion. Heart tissue can be damaged during angioplasty, often leading to additional procedures, poor outcomes and higher health care costs. In this trial, researchers compared a single dose of ...

Clot-busting drug as effective as angioplasty

2013-03-12
SAN FRANCISCO (March 10, 2013) — A clot-busting therapy may benefit some heart attack patients who cannot have immediate angioplasty, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. "Drug therapy before transfer is at least as effective as [angioplasty], and an urgent catheterization was avoided in two-thirds of patients," said Frans Van de Werf, MD, PhD, professor of cardiology at University of Leuven, Belgium, and the study's lead investigator. "It gives [clinicians] time to consider other options, such ...

Drug reduces chest pain in patients with diabetes

2013-03-12
SAN FRANCISCO (March 10, 2013) — A commonly used anti-anginal drug reduces chest pain in patients with type 2 diabetes and appears to have a more pronounced effect in those with poorer glucose control, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. Ranolazine is approved by the U.S. Food and Drug Administration for the treatment of chronic angina, or chest pain, both as first line therapy and as an add-on when symptoms are not relieved with other anti-anginal drugs, including beta-blockers, calcium channel ...

High-dose oral vitamins, minerals do not reduce recurrent cardiac events in heart attack patients

2013-03-12
SAN FRANCISCO (March 10, 2013) — Heart attack patients given a combination of high-dose oral vitamins and minerals do not exhibit a significant reduction in recurrent cardiac events, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. However, the results of one component of the NIH-funded Trial to Assess Chelation Therapy (TACT) study, shows that when combined with active chelation therapy, high-dose vitamins and minerals may provide some additional benefit. The TACT study tested the safety and effectiveness of ...

Digoxin reduces hospital admissions in older patients with chronic heart failure

2013-03-12
SAN FRANCISCO (March 11, 2013) —Digoxin significantly reduces the likelihood of hospital admission due to all causes among ambulatory older patients with chronic heart failure and reduced ejection fraction (HFrEF), according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. Researchers reviewed patient outcomes from 1995 in the Digitalis Investigation Group (DIG) trial of 6,800 patients with HFrEF—a condition in which the heart is too weak to pump and patients suffer from breathlessness and fatigue. Patients with HFrEF ...

Clot-busting drug benefits intermediate-risk patients with pulmonary embolism

2013-03-12
SAN FRANCISCO (March 11, 2013) — The clot-busting drug tenecteplase prevents death or circulatory collapse in a subgroup of patients with a blood clot in the lungs and appears to be especially useful in patients younger than 75, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. Pulmonary embolism occurs when part of a blood clot in a vein breaks off and travels to the lungs. It is fatal about 10 percent of the time, killing between 60,000 and 100,000 Americans each year. The most common cause of death is progressive ...

Screenings, targeted care reduce heart failure in at-risk patients

2013-03-12
SAN FRANCISCO (March 11, 2013) — For at-risk patients, a simple screening and management program can be effective in preventing heart failure, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. The five-year STOP-HF study enrolled asymptomatic patients over 40 years of age with risk factors for heart failure and randomized them into an intervention and a control group. Patients in the intervention group were screened for blood levels of B-type natriuretic peptide (BNP), a hormone that indicates how well the heart ...

No benefit found from BP drug in treatment of recently hospitalized heart failure patients

2013-03-12
SAN FRANCISCO (March 11, 2013) —Despite high hopes that a blood pressure-lowering medication called aliskiren would help people following hospitalization for heart failure, no beneficial effects were found, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. Heart failure is the leading cause of hospitalization for people over age 65, costing Medicare billions of dollars annually, and researchers are always on the lookout for more effective treatments. The Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT) ...

Erectile dysfunction drug fails for diastolic heart failure patients

2013-03-12
SAN FRANCISCO (March 11, 2013) — Despite high expectations for a commonly used erectile dysfunction drug to treat patients with diastolic heart failure, no beneficial effects were found in a study presented today at the American College of Cardiology's 62nd Annual Scientific Session. The RELAX Study is the first multicenter trial to look at the effect of chronic therapy with sildenafil in diastolic heart failure. Sildenafil is a phosphodiesterase-5 (PDE-5) inhibitor, a class of drugs used to treat erectile dysfunction and certain types of pulmonary arterial hypertension. ...

LAST 30 PRESS RELEASES:

Novel stem cell therapy repairs irreversible corneal damage in clinical trial

News article or big oil ad? As native advertisements mislead readers on climate change, Boston University experts identify interventions

Advanced genetic blueprint could unlock precision medicine

Study: World’s critical food crops at imminent risk from rising temperatures

Chemistry: Triple bond formed between boron and carbon for the first time

How a broken bone from arm wrestling led to a paradigm shift in mental health: Exercise as a first-line treatment for depression

Alarming levels of microplastics discovered in human brain tissue, linked to dementia

Global neurology leader makes The Neuro world's first open science institute

Alpha particle therapy emerges as a potent weapon against neuroendocrine tumours

Neuroscience beyond boundaries: Dr. Melissa Perreault bridges Indigenous knowledge and brain science

Giant clone of seaweed in the Baltic Sea

Motion capture: In world 1st, M. mobile’s motility apparatus clarified

One-third of older Canadians at nutritional risk, study finds

Enhancing climate action: satellite insights into fossil fuel CO2 emissions

Operating a virtual teaching and research section as an open source community: Practice and experience

Lack of medical oxygen affects millions

Business School celebrates triple crown

Can Rhizobium + low P increase the yield of common bean in Ethiopia?

Research Security Symposium on March 12

Special type of fat tissue could promote healthful longevity and help maintain exercise capacity in aging

Researchers develop high-water-soluble pyrene tetraone derivative to boost energy density of aqueous organic flow batteries

Who gets the lion’s share? HKU ecologists highlight disparities in global biodiversity conservation funding

HKU researchers unveil neuromorphic exposure control system to improve machine vision in extreme lighting environments

Researchers develop highly robust, reconfigurable, and mechanochromic cellulose photonic hydrogels

Researchers develop new in-cell ultraviolet photodissociation top-down mass spectrometry method

Researchers develop innovative tool for rapid pathogen detection

New insights into how cancer evades the immune system

3 Ways to reduce child sexual abuse rates

A third of children worldwide forecast to be obese or overweight by 2050

Contraction inhibitors after 30 weeks have no effect on baby's health

[Press-News.org] Logging debris gives newly planted Douglas-fir forests a leg-up
Retaining moderate levels of 'slash' linked to increased early growth in seedlings